Drug firms eye small biotechs
Philadelphia Daily News - Zoloft, Pfizer's $3.3 billion depression treatment, lost patent protection this year, while Zithromax, its $2 billion infection fighter, lost protection in 2005. Lipitor, its $12.2 billion cholesterol medication, becomes fair game for generics in 2011
Source: www.philly.com
FDA Panels Urges Changes to Antidepressant Labeling
Forbes - were based on fears that taking anti-depressants could increase the risk of suicide ideation, many psychiatrists worry that the "black-box warning" will backfire -- resulting in more suicides as patients shy away from depression treatment. Expanding
Source: www.forbes.com
Click here for more information about women and depression women and depression
<< Home